These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
94-1517641
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
Large accelerated filer
o
|
Accelerated filer
o
|
|
|
Non-accelerated filer
o
|
Smaller reporting company
x
|
|
|
(do not check if a smaller reporting company)
|
||
|
PART I
|
Financial Information
|
|
|
Item 1
|
Financial Statements
|
|
|
Condensed Consolidated Balance Sheets as of June 30, 2012 (Unaudited) and December 31, 2011
|
3
|
|
|
Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2012 and 2011
|
4
|
|
|
Unaudited Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2012 and 2011
|
5
|
|
|
Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2012 and 2011
|
6
|
|
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
7
|
|
|
Item 2
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
27
|
|
Item 3
|
Quantitative and Qualitative Disclosures about Market Risk
|
31
|
|
Item 4
|
Controls and Procedures
|
31
|
|
PART II
|
Other Information
|
|
|
Item 1
|
Legal Proceedings
|
32
|
|
Item 1A
|
Risk Factors
|
32
|
|
Item 6
|
Exhibits
|
32
|
|
SIGNATURES
|
33
|
|
|
EXHIBITS
|
|
June
30, 2012
|
December
31, 2011
|
|||||||
|
ASSETS
|
(Unaudited)
|
|||||||
|
Current assets:
|
||||||||
|
Cash
|
$
|
11,275
|
$
|
12,940
|
||||
|
Accounts receivable
|
1,725
|
3,345
|
||||||
|
Prepaid expenses and other current assets
|
327
|
234
|
||||||
|
Total current assets
|
13,327
|
16,519
|
||||||
|
Property and equipment, net
|
332
|
108
|
||||||
|
Total assets
|
$
|
13,659
|
$
|
16,627
|
||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
351
|
$
|
447
|
||||
|
Accrued expenses
|
776
|
601
|
||||||
|
Deferred revenue
|
1,543
|
1,906
|
||||||
|
Total current liabilities
|
2,670
|
2,954
|
||||||
|
Total liabilities
|
2,670
|
2,954
|
||||||
|
Commitments and contingencies (Note 8)
|
||||||||
|
Stockholders' equity:
|
||||||||
|
Series A Preferred stock, 444,541 shares authorized with par value $0.001 per share; 83 shares issued and outstanding at June 30, 2012 and
December 31, 2011. (In the event of dissolution,
each share of Series A Preferred stock has a liquidation preference equal to
par value of $0.001 over the shares of common stock)
|
- | - | ||||||
|
Series B Preferred stock, 54,425 shares authorized with par
value $0.001 per share; 95 and 114 shares issued and outstanding
at June 30, 2012 and December 31, 2011, respectively. (In the event of
dissolution, each share of Series B Preferred stock has a liquidation
preference equal to par value of $0.001 over the shares of common stock)
|
- | - | ||||||
|
Common stock, 70,000,000 shares authorized with par value $0.001 per share;
32,972,631 and 32,778,993 shares issued and outstanding at
June 30, 2012 and December 31, 2011, respectively
|
33
|
33
|
||||||
|
Additional paid-in capital
|
145,314
|
142,955
|
||||||
|
Accumulated other comprehensive (loss) income
|
(15)
|
13
|
||||||
|
Accumulated deficit
|
(134,343
|
)
|
(129,328
|
)
|
||||
|
Total stockholders' equity
|
10,989
|
13,673
|
||||||
|
Total liabilities and stockholders' equity
|
$
|
13,659
|
$
|
16,627
|
||||
|
Three months ended June 30,
|
Six months ended June 30,
|
|||||||||||||||
|
2012
|
2011
|
2012
|
2011
|
|||||||||||||
|
Net revenues
|
$
|
1,974
|
$
|
283
|
$
|
3,138
|
$
|
822
|
||||||||
|
Cost of revenues
|
494
|
238
|
743
|
393
|
||||||||||||
|
Gross margin
|
1,480
|
45
|
2,395
|
429
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Product research and development
|
1,478
|
382
|
2,165
|
658
|
||||||||||||
|
Sales and marketing
|
1,718
|
363
|
2,517
|
715
|
||||||||||||
|
General and administrative
|
1,691
|
921
|
2,686
|
1,785
|
||||||||||||
|
Total operating expenses
|
4,887
|
1,666
|
7,368
|
3,158
|
||||||||||||
|
Operating loss
|
(3,407
|
)
|
(1,621
|
)
|
(4,973
|
)
|
(2,729
|
)
|
||||||||
|
Other expense, net:
|
||||||||||||||||
|
Interest expense
|
--
|
(81
|
)
|
--
|
(135
|
)
|
||||||||||
|
Non-cash items related to debt discounts and
|
||||||||||||||||
|
deferred financing fees and the valuation of
|
||||||||||||||||
|
conversion features and warrants
|
--
|
(1,014
|
)
|
--
|
(9,568
|
)
|
||||||||||
|
Total other expense, net
|
--
|
(1,095
|
)
|
--
|
(9,703
|
)
|
||||||||||
|
Loss before provision for income taxes
|
(3,407
|
)
|
(2,716
|
)
|
(4,973
|
)
|
(12,432
|
)
|
||||||||
|
Provision for income taxes
|
20
|
6
|
42
|
11
|
||||||||||||
|
Net loss
|
$
|
(3,427
|
)
|
$
|
(2,722
|
)
|
$
|
(5,015
|
)
|
$
|
(12,443
|
)
|
||||
|
Loss per common share:
|
||||||||||||||||
|
Basic and diluted loss per share
|
$
|
(0.10
|
)
|
$
|
(0.10
|
)
|
$
|
(0.15
|
)
|
$
|
(0.50
|
)
|
||||
|
Basic and diluted – weighted average shares used in per share computations
|
32,969
|
27,642
|
32,889
|
25,039
|
||||||||||||
|
Three months ended June 30,
|
Six months ended June 30,
|
|||||||||||||||
|
2012
|
2011
|
2012
|
2011
|
|||||||||||||
|
Net loss
|
$
|
(3,427
|
)
|
$
|
(2,722
|
)
|
$
|
(5,015
|
)
|
$
|
(12,443
|
)
|
||||
|
Other comprehensive income (loss):
|
||||||||||||||||
|
Foreign currency translation adjustments
|
(72
|
)
|
(21
|
)
|
(28
|
)
|
18
|
|||||||||
| Total comprehensive loss |
$
|
(3,499
|
)
|
$
|
(2,743
|
)
|
$
|
(5,043
|
)
|
$
|
(12,425
|
)
|
||||
|
Six months ended June 30,
|
||||||||
|
2012
|
2011
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$
|
(5,015
|
)
|
$
|
(12,443
|
)
|
||
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
|
Stock-based compensation expense
|
2,351
|
472
|
||||||
|
Depreciation and amortization
|
40
|
10
|
||||||
|
Debt discounts and deferred financing fees and the valuation of conversion
|
||||||||
|
features and warrants
|
--
|
9,569
|
||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
1,623
|
(2,961
|
)
|
|||||
|
Other assets
|
--
|
--
|
||||||
|
Prepaid expenses
|
(96
|
)
|
(70
|
)
|
||||
|
Accounts payable and accrued expenses
|
87
|
(160
|
)
|
|||||
|
Deferred revenue
|
(363
|
)
|
2,535
|
|||||
|
Net cash used in operating activities
|
(1,373
|
)
|
(3,048
|
)
|
||||
|
Cash flows from investing activities:
|
||||||||
|
Purchase of property and equipment
|
(268
|
)
|
(25
|
)
|
||||
|
Net cash used in investing activities
|
(268
|
)
|
(25
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from issuance of convertible debt
|
--
|
4,228
|
||||||
|
Repayment of convertible debt
|
--
|
(25
|
)
|
|||||
|
Proceeds from exercise of warrants
|
8
|
515
|
||||||
|
Net cash provided by financing activities
|
8
|
4,718
|
||||||
|
Effect of exchange rate changes on cash
|
(32
|
)
|
3
|
|||||
|
Net (decrease) increase in cash
|
(1,665
|
)
|
1,648
|
|||||
|
Cash at beginning of period
|
12,940
|
911
|
||||||
|
Cash at end of period
|
$
|
11,275
|
$
|
2,559
|
||||
|
Supplemental disclosure of cash flow information:
|
||||||||
|
Interest paid
|
$
|
--
|
$
|
90
|
||||
|
Income taxes paid
|
$
|
42
|
$
|
4
|
||||
|
Supplemental disclosure of non-cash transactions:
|
||||||||
|
Fair value of shares of common stock and warrants issued
|
||||||||
|
to brokers in connection with financing, recorded as debt
|
||||||||
|
issuance costs
|
$
|
--
|
$
|
1
|
||||
|
Debt discount recorded as part of convertible debt financing
|
||||||||
|
transactions including, warrants issued
|
$
|
--
|
$
|
4,228
|
||||
|
Debt issuance costs related to 2011 financing
|
$
|
--
|
$
|
35
|
||||
|
Accrued expenses converted to common stock
|
$
|
--
|
$
|
120
|
||||
|
Conversion of debt and accrued interest to common stock
|
$
|
--
|
$
|
2,860
|
||||
|
Reduction of derivative liabilities upon conversion of debt
|
$
|
--
|
$
|
13,379
|
||||
|
Computer equipment
|
3 years
|
|
Furniture and fixtures
|
5 years
|
|
●
|
Amazon - 53%
|
|
●
|
Kobo - 11%
|
|
●
|
Sony Corporation - 11%
|
|
●
|
Amazon - 53%
|
|
●
|
Sony Corporation – 13%
|
|
●
|
Dividends and Distributions.
|
|
Series A Preferred:
|
The holders of shares of Series A Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series A Preferred stock held by them.
|
|
Series B Preferred:
|
The holders of shares of Series B Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series B Preferred stock held by them.
|
|
●
|
Liquidation Preference.
|
|
Series A Preferred:
|
In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of any other series of Preferred stock to be established by the Board of Directors (the “Senior Preferred Stock”), the holders of Series A Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series A Preferred stock then outstanding.
|
|
Series B Preferred:
|
In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of the Series A Preferred stock and Senior Preferred Stock, the holders of Series B Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series B Preferred stock then outstanding.
|
|
●
|
Voting.
|
|
●
|
Conversion.
|
|
Shares of Preferred Stock Not Exchanged as of June 30, 2012
|
Conversion Ratio
|
Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at June 30, 2012
|
||||||||||
|
Series A Preferred stock
|
83
|
480.63
|
39,892
|
|||||||||
|
Series B Preferred stock
|
95
|
132.07
|
12,547
|
|||||||||
|
Total Remaining Not Exchanged
|
178
|
52,439
|
||||||||||
| For the Six | ||||
|
Months Ended
June 30, 2011
|
||||
|
Annual dividend yield
|
--
|
|||
|
Expected life (years)
|
0.08 – 3.0
|
|||
|
Risk-free interest rate
|
0.08%- 1.27%
|
|
||
|
Expected volatility
|
110% - 263%
|
|
||
|
●
|
The 1998 Non-Officer Stock Option Plan (the 1998 Plan), which expired in June 2008 ;
|
|
●
|
The 2006 Equity Incentive Plan (the 2006 Plan).
|
|
●
|
The 2001 Non-Employee Director Stock Option Plan (the Director Plan), which expired in March 2011.
|
|
|
Number of Options Outstanding
|
Weighted Average Exercise Price
|
||||||
|
Outstanding at January 1, 2012
|
19,324
|
$
|
92.19
|
|||||
|
Granted
|
1,460,000
|
4.26
|
||||||
|
Cancelled or expired
|
(8,124
|
)
|
69.36
|
|||||
|
Exercised
|
---
|
---
|
||||||
|
Outstanding at June 30, 2012
|
1,471,200
|
$
|
6.79
|
|||||
|
For the Six
|
||||
|
Months Ended
June 30, 2012
|
||||
|
Annual dividend yield
|
--
|
|||
|
Expected life (years)
|
3.8
|
|||
|
Risk-free interest rate
|
0.55% - 0.57%
|
|||
|
Expected volatility
|
186% - 187%
|
|
||
|
Three months
ended
June 30,
2011
|
Three months
ended
June 30,
2012
|
|||||||
|
Stock-based compensation
|
$ | 183 | $ | 2,317 | ||||
|
Six months
ended
June 30,
2011
|
Six months
ended
June 30,
2012
|
Remaining unamortized
expense at
June 30,
2012
|
||||||||||
|
Stock-based compensation
|
$
|
472
|
$
|
2,351
|
$
|
3,607
|
||||||
|
June 30, 2012
|
||||||||||||
|
Outstanding and exercisable
|
Warrants
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Remaining
Contractual
Life
|
|||||||||
|
January 1, 2012
|
5,405,606
|
$
|
1.57
|
2.45
|
||||||||
|
Issued
|
--
|
$
|
--
|
--
|
||||||||
|
Expired/forfeited
|
--
|
--
|
--
|
|||||||||
|
Exercised
|
(223,500
|
)
|
$
|
0.61
|
--
|
|||||||
|
Outstanding and exercisable, June 30, 2012
|
5,182,106
|
$
|
1.61
|
1.87
|
||||||||
|
Below is a summary of Outstanding Warrants to Purchase
Common Stock as of June 30, 2012:
|
||||||||||
|
Description
|
Issue Date
|
Exercise Price
|
Shares
|
Expiration Date
|
||||||
|
September 2007 Investor Warrant
|
9/26/2007
|
$
|
31.75
|
233
|
9/26/2012
|
|||||
|
August 2009 Employee Warrants
|
8/25/2009
|
$
|
0.50
|
240,000
|
8/25/2016
|
|||||
|
January 2010 Investor Warrant
|
1/28/2010
|
$
|
1.00
|
40,000
|
1/28/2013
|
|||||
|
2007 Debt Extension Warrants
|
9/22/2010
|
$
|
1.00
|
16,000
|
9/22/2015
|
|||||
|
September 2010 Repricing Warrant
|
9/28/2010
|
$
|
1.38
|
4,000
|
9/28/2013
|
|||||
|
October 2010 Repricing Warrants
|
10/18/2010
|
$
|
1.38
|
2,434,830
|
10/18/2013
|
|||||
|
October 2010 Employee Warrants
|
10/15/2010
|
$
|
1.38
|
1,440,000
|
10/15/2013
|
|||||
|
December 2010 Employee Warrants
|
12/3/2010
|
$
|
1.63
|
200,000
|
12/3/2015
|
|||||
|
January 2011 Employee Warrant
|
1/21/2011
|
$
|
2.00
|
20,000
|
1/21/2014
|
|||||
|
February 2011 Legal Advisor Warrant
|
2/22/2011
|
$
|
2.00
|
80,000
|
2/22/2016
|
|||||
|
March 2011 Investor Warrants
|
3/9/2011
|
$
|
3.13
|
617,943
|
3/9/2016
|
|||||
|
March 2011 Investor Warrants
|
4/7/2011
|
$
|
3.13
|
49,100
|
4/7/2016
|
|||||
|
May 2011 Consultant Warrant
|
5/17/2011
|
$
|
4.05
|
20,000
|
5/17/2014
|
|||||
|
September 2011 Employee Warrant
|
9/12/2011
|
$
|
3.90
|
20,000
|
9/12/2014
|
|||||
|
Total Warrants Outstanding
|
5,182,106
|
|||||||||
|
Three months ended
June 30, 2012
|
Three months ended
June 30, 2011
|
|||||||||||||||
|
Amount
|
Percentage
|
Amount
|
Percentage
|
|||||||||||||
|
Net revenues made in the U.S.
|
$
|
1,218
|
62
|
%
|
$
|
130
|
46
|
%
|
||||||||
|
Net revenues made outside of the U.S.
|
756
|
38
|
%
|
153
|
54
|
%
|
||||||||||
|
$
|
1,974
|
100
|
%
|
$
|
283
|
100
|
%
|
|||||||||
|
Six months ended
June 30, 2012
|
Six months ended
June 30,
2011
|
|||||||||||||||
|
Amount
|
Percentage
|
Amount
|
Percentage
|
|||||||||||||
|
Net revenues made in the U.S.
|
$
|
2,000
|
64
|
%
|
$
|
130
|
16
|
%
|
||||||||
|
Net revenues made outside of the U.S.
|
1,138
|
36
|
%
|
692
|
84
|
%
|
||||||||||
|
$
|
3,138
|
100
|
%
|
$
|
822
|
100
|
%
|
|||||||||
|
Three Months ended
|
||||||||
|
(in thousands, except per share amounts)
|
June 30,
|
|||||||
|
2012
|
2011
|
|||||||
|
BASIC AND DILUTED
|
||||||||
|
Weighted average number of
|
||||||||
|
common shares outstanding
|
32,969
|
27,642
|
||||||
|
Number of shares for computation of
|
||||||||
|
net loss per share
|
32,969
|
27,642
|
||||||
|
Net loss
|
$
|
(3,427
|
)
|
$
|
(2,722
|
)
|
||
|
Net loss per share - basic and diluted
|
$
|
(0.10
|
)
|
$
|
(0.10
|
)
|
||
|
Six Months ended
|
||||||||
|
(in thousands, except per share amounts)
|
June 30,
|
|||||||
|
2012
|
2011
|
|||||||
|
BASIC AND DILUTED
|
||||||||
|
Weighted average number of
|
||||||||
|
common shares outstanding
|
32,889
|
25,039
|
||||||
|
Number of shares for computation of
|
||||||||
|
net loss per share
|
32,889
|
25,039
|
||||||
|
Net loss
|
$
|
(5,015
|
)
|
$
|
(12,443
|
)
|
||
|
Net loss per share - basic and diluted
|
$
|
(0.15
|
)
|
$
|
(0.50
|
)
|
||
|
●
|
actual versus anticipated licensing of our technology;
|
|
●
|
our actual versus anticipated operating expenses;
|
|
●
|
the timing of our OEM customer product shipments;
|
|
●
|
the timing of payment for our technology licensing agreements;
|
|
●
|
our actual versus anticipated gross profit margin;
|
|
●
|
our ability to raise additional capital, if necessary; and
|
|
●
|
our ability to secure credit facilities, if necessary.
|
|
Depreciation and amortization
|
$
|
40
|
||
|
Stock-based compensation expense
|
2,351
|
|||
|
Total net non-cash items included in cash provided by our operations
|
$
|
2,391
|
|
●
|
We added personnel to our accounting department, consultants, or other resources (including those with public company reporting experience) to enhance our policies and procedures, including those related to complex accounting issues;
|
|
|
●
|
We retained a Sarbanes-Oxley consulting firm to assist us to prepare written policies and procedures for accounting and financial reporting to establish a formal process to close our books and account for all transactions.
|
|
Exhibit #
|
Description
|
||
|
3.1
|
Amended and Restated Certificate of Incorporation of Neonode Inc., dated April 17, 2009 (incorporated by reference to Exhibit 10.22 of our Quarterly Report on Form 10-Q filed on August 4, 2009).
|
||
|
3.1.1
|
Certificate of Amendment, dated December 13, 2010 (incorporated by reference to Exhibit 3.1.1 of our Annual Report on Form 10-K filed on March 31, 2011)
|
||
|
3.1.2
|
Certificate of Amendment, dated March 18, 2011 (incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K filed on March 28, 2011)
|
||
|
3.1.3
|
Certificate of Correction, dated February 29, 2011 (incorporated by reference to Exhibit 3.1.3 of our Annual Report on Form 10-K filed on March 31, 2011)
|
||
|
3.2
|
Bylaws, as amended through December 5, 2007 (incorporated by reference to Exhibit 3.2 of our Annual Report on Form 10-K filed on April 15, 2008)
|
||
|
31.1
|
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act Of 2002
|
||
|
31.2
|
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act Of 2002
|
||
|
32.1
|
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
101
|
The following materials from the Company’s Form 10-Q for the quarter ended June 30, 2012 and 2011, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets; (ii) Consolidated Statements of Operations; (iii) Consolidated statements of Comprehensive Loss; (iv) Consolidated Statements of Cash Flows; and (v) Notes to Consolidated Financial Statements*
|
||
|
Neonode Inc.
Registrant
|
|||
|
Date: August 14, 2012
|
By:
|
/s/ David W. Brunton
|
|
|
David W. Brunton
|
|||
|
Chief Financial Officer,
|
|||
|
Vice President, Finance
|
|||
|
and Secretary
|
|||
|
(Principal Financial and
|
|||
|
Accounting Officer)
|
|||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|